Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01283048
Title Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Toni Choueiri, MD

renal cell carcinoma


Bevacizumab + Buparlisib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.